Abstract:Competitive bacteria-bacteriophage interactions have resulted in the evolution of a plethora of bacterial defense systems preventing phage propagation. In recent years, computational and bioinformatic approaches have underpinned the discovery of numerous novel bacterial defense systems. Anti-phage systems are frequently encoded together in genomic loci termed defense islands. Here we report the identification and characterisation of a novel anti-phage system, that we have termed Shield, which forms part of the Pseudomonas defensive arsenal. The Shield system comprises the core component ShdA, a membrane-bound protein harboring an RmuC domain. Heterologous production of ShdA alone is sufficient to mediate bacterial immunity against several phages. We demonstrate that Shield and ShdA confer population-level immunity and that they can also decrease transformation efficiency. We further show that ShdA homologues can degrade DNA in vitro and, when expressed in a heterologous host, can alter the organisation of the host chromosomal DNA. Use of comparative genomic approaches identified how Shield can be divided into four subtypes, three of which contain additional components that in some cases can negatively affect the activity of ShdA and/or provide additional lines of phage defense. Collectively, our results identify a new player within the Pseudomonas bacterial immunity arsenal that displays a novel mechanism of protection, and reveals a role for RmuC domains in phage defense. The evolutionary pressure exerted by bacteriophages has driven bacteria to acquire numerous defense systems. Recent studies have highlighted the extraordinary diversity of these systems, uncovering exciting links between bacterial and eukaryotic immunity. Here we describe a novel anti-phage system, named Shield, found within Pseudomonas species. We identify several Shield subtypes, all harboring the same core component, and describe its mode of action. The growing instance of multidrug-resistant bacterial infections urgently requires the development of alternative treatments. Phage therapy is a particularly pertinent approach to treat multi-drug resistant Pseudomonas aeruginosa strains causing severe lung infection in cystic fibrosis patients. A detailed understanding of bacterial immunity and phage counter-strategies is an essential step to underpin the rational design of phage therapy to fight disease.

PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense

Molecular and structural basis of an ATPase-nuclease dual-enzyme anti-phage defense complex

A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin

TcpC Inhibits Neutrophil Extracellular Trap Formation by Enhancing Ubiquitination Mediated Degradation of Peptidylarginine Deiminase 4

SspABCD–SspE is a Phosphorothioation-Sensing Bacterial Defence System with Broad Anti-Phage Activities

Molecular basis of the phosphorothioation-sensing antiphage defense system IscS–DndBCDE–DndI

Structural Insights on the Bacteriolytic and Self-protection Mechanism of Muramidase Effector Tse3 in Pseudomonas Aeruginosa

Structural basis for the concerted antiphage activity in the SIR2–HerA system

Assembly-mediated activation of the SIR2-HerA supramolecular complex for anti-phage defense

A Bacterial “shield and Sword”: A Previously Uncharacterized Two-Component System Protects Uropathogenic Escherichia Coli from Host-Derived Oxidative Insults and Promotes Hemolysin-Mediated Host Cell Pyroptosis

Structural and functional characterization of cyclic pyrimidine-regulated anti-phage system

Topological rearrangements activate the HerA-DUF anti-phage defense system

Amidase and Lysozyme Dual Functions in TseP Reveal a New Family of Chimeric Effectors in the Type VI Secretion System

The role of TIR domain-containing proteins in bacterial defense against phages

Crystal Structure of Type Vi Effector Tse1 from Pseudomonas Aeruginosa

Architecture and infection-sensing mechanism of the bacterial PARIS defense system

The novel anti-phage system Shield co-opts an RmuC domain to mediate phage defense across Pseudomonas species

Structures and activation mechanism of the Gabija anti-phage system

Bacteria conjugate ubiquitin-like proteins to interfere with phage assembly

Architecture and activation mechanism of the bacterial PARIS defence system

Structural and SAXS analysis of Tle5-Tli5 complex reveals a novel inhibition mechanism of H2-T6SS in Pseudomonas aeruginosa